[ad_1]
Moderna chief of staff set up new bells in the financial markets on Tuesday with a warning that the existing COVID-19 vaccine may not be as effective against the Omicron brand as it does against the Delta brand.
Europe’s leading markets dropped by about 1.5 percent in the first quarter, Tokyo’s Nikkei index closed 1.6 percent, oil futures fell by more than 3 percent, and the Australian dollar declined one year after Stephane Bancel’s comments sparked fears the vaccine resistance could extend. plague.
“There is no country, I think, where [the effectiveness] it’s the same part … we had with Delta, “Bancel told the Financial Times.
“I think it will be a little bit. I don’t know how many because we have to wait for the data. But all the scientists I’ve talked to … are like ‘this is not going to be good’,” Bancel said.
Comparing this, however, the Executive Director of the European Medicines Agency (EMA) Emer Cooke told the European Parliament that even though the new species has spread, existing vaccines will continue to protect.
Moderna did not respond to a request from the Reuters news agency, nor did she say she hoped to have information about how her vaccine works against Omicron, which the World Health Organization (WHO) says is at high risk of contracting the disease.
A new type of vaccine
Bancel had previously told a CNBC reporter that it could take months to launch a new nationwide vaccine.
The WHO and scientists have also said that it could take weeks to understand if Omicron could cause a deadly disease or escape the immune system caused by a vaccine.
Cooke said lab testing for “political neutrality” could take about two weeks. If a COVID-19 vaccine is needed, new ones can be approved within three to four months, he added.
“Vaccines can still save you in the hospital,” says John Wherry, director of the Penn Institute for Immunology in Philadelphia.
Moderna and its BioNTech product manufacturers and Johnson & Johnson are working on a vaccine that looks specifically at Omicron if existing shots will not work. Moderna has also tested a higher level of available additives.
Doubts about the new reforms have sparked a global warning, the closure of the frontier casts a shadow over the economic recovery due to the two-year epidemic.
News of his release slammed nearly $ 2 trillion in global prices on Friday, but another calm came Monday.
“Omicron-type information is graphic, how its signals will be and how easily they can be transmitted is no longer known, as modern vaccines work,” said Kelvin Wong, an expert at CMC Markets (Singapore) Pte. “I expect more risk in the next few weeks unless there is a clear indication of the omicron problem.”
Doubts about the vaccine covered many positive impressions from China, which showed that industrial sentiment improved in November with a sharp drop in electricity prices and a drop in prices. China’s Hang Seng stock gauge has been closed at the lowest level since May 2016.
Elsewhere, upcoming markets fell for the third day, while the benchmark index dropped for one year. Anti-risk threats also disrupted cryptocurrencies, with Bitcoin falling to $ 56,000.
Correction of boundaries
Omicron was first detained in Southern Africa last week, known to have spread to more than a dozen countries, prompting many to tighten borders in an effort to stem the tide of last year’s tight end and the recession.
International routes for travelers from Southern Africa, where the virus was first identified, have highlighted the inequality of the distribution of the vaccine, which would have allowed the virus to adapt.
“African people cannot be held accountable for the lack of vaccines in Africa – and they should not be punished for recognizing and sharing vital scientific and health information with the world,” UN Secretary-General Antonio Guterres said.
A European passenger plane stopped in Cape Town on Tuesday, marking the start of South Africa’s first maritime season, with many tourist attractions since the epidemic.
When the Omicron is found at sea, many passengers are expected to fly home.
India, the world’s largest producer of vaccines, has approved the COVID-19 vaccine in many African countries and says it is “ready” to export. China has also pledged to provide one billion dollars to the continent.
[ad_2]
Source link
